View in EDS

144P Clinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs.

Saved in:
Bibliographic Details
Title: 144P Clinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs.
Authors: Passaro, A1 (AUTHOR), Prelaj, A1 (AUTHOR), Spitaleri, G1 (AUTHOR), Signore, E Del1 (AUTHOR), Rossi, G1 (AUTHOR), Guerini-Rocco, E2 (AUTHOR), Barberis, M2 (AUTHOR), Catania, C1 (AUTHOR), Marinis, F de1 (AUTHOR)
Source: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdz063.042